BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35682564)

  • 1. Molecular and Genetic Interactions between CCN2 and CCN3 behind Their Yin-Yang Collaboration.
    Kubota S; Kawata K; Hattori T; Nishida T
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
    Peidl A; Perbal B; Leask A
    PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
    Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
    Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.
    Kawaki H; Kubota S; Suzuki A; Lazar N; Yamada T; Matsumura T; Ohgawara T; Maeda T; Perbal B; Lyons KM; Takigawa M
    J Bone Miner Res; 2008 Nov; 23(11):1751-64. PubMed ID: 18597638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Imaging of CCN2 and CCN3 in Living Cells.
    Hattori T; Hoshijima M; Takigawa M
    Methods Mol Biol; 2017; 1489():211-215. PubMed ID: 27734379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of heterotypic CCN2/CTGF-CCN3/NOV and homotypic CCN2-CCN2 interactions in expression of the differentiated phenotype of chondrocytes.
    Hoshijima M; Hattori T; Aoyama E; Nishida T; Yamashiro T; Takigawa M
    FEBS J; 2012 Oct; 279(19):3584-3597. PubMed ID: 22812570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RFX1-mediated CCN3 induction that may support chondrocyte survival under starved conditions.
    Mizukawa T; Nishida T; Akashi S; Kawata K; Kikuchi S; Kawaki H; Takigawa M; Kamioka H; Kubota S
    J Cell Physiol; 2021 Oct; 236(10):6884-6896. PubMed ID: 33655492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor β controls CCN3 expression in nucleus pulposus cells of the intervertebral disc.
    Tran CM; Smith HE; Symes A; Rittié L; Perbal B; Shapiro IM; Risbud MV
    Arthritis Rheum; 2011 Oct; 63(10):3022-31. PubMed ID: 21618206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
    Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
    J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic regulation of the CCN family genes by glycolysis in chondrocytes.
    Akashi S; Nishida T; El-Seoudi A; Takigawa M; Iida S; Kubota S
    J Cell Commun Signal; 2018 Mar; 12(1):245-252. PubMed ID: 29129024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.
    Riser BL; Najmabadi F; Perbal B; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC; Peterson DR
    J Cell Commun Signal; 2010 Mar; 4(1):39-50. PubMed ID: 20195391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary mRNA expression of CCN2/CCN3 as a noninvasive marker for monitoring glomerular structure changes in nondiabetic chronic kidney disease.
    Chen L; Wu YG; Liu D; Lv LL; Zheng M; Ni HF; Cao YH; Liu H; Zhang P; Zhang JD; Liu BC
    Biomarkers; 2012 Dec; 17(8):714-20. PubMed ID: 23061738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2.
    Leask A
    J Cell Commun Signal; 2009 Jun; 3(2):161-2. PubMed ID: 19475498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).
    Li J; Ye L; Owen S; Weeks HP; Zhang Z; Jiang WG
    Int J Mol Med; 2015 Dec; 36(6):1451-63. PubMed ID: 26498181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.
    Abd El Kader T; Kubota S; Janune D; Nishida T; Hattori T; Aoyama E; Perbal B; Kuboki T; Takigawa M
    J Cell Commun Signal; 2013 Mar; 7(1):11-8. PubMed ID: 23065484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein.
    Bohr W; Kupper M; Hoffmann K; Weiskirchen R
    PLoS One; 2010 Dec; 5(12):e16000. PubMed ID: 21209863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do not overwork: cellular communication network factor 3 for life in cartilage.
    Kubota S; Kawaki H; Perbal B; Takigawa M; Kawata K; Hattori T; Nishida T
    J Cell Commun Signal; 2023 Jun; 17(2):353-359. PubMed ID: 36745317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CCN3 on fibroblast proliferation, apoptosis and extracellular matrix production.
    Ren Z; Hou Y; Ma S; Tao Y; Li J; Cao H; Ji L
    Int J Mol Med; 2014 Jun; 33(6):1607-12. PubMed ID: 24715059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
    Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
    Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for CCN3 (NOV) in calcium signalling.
    Li CL; Martinez V; He B; Lombet A; Perbal B
    Mol Pathol; 2002 Aug; 55(4):250-61. PubMed ID: 12147716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.